Other resolutive chemokines (RANTES/CCL5, MIP2/CXCL2, MDC/CCL22), and cytokines IL-1RA and IL-10 were quantified in SuperMApo (Supplementary Figure 5A) and thus added to recombinant TGF-β (all in similar quantity than measured in SuperMApo) to treat arthritis. The gene discussed is CCL22; the disease is arthritic joint disease.